MR-guided radiation for ultra-central lung tumors
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a precise type of radiation (stereotactic body radiotherapy) using a special MRI-guided machine for lung tumors that are very close to the main airways. It might help patients who cannot have surgery and whose tumor is in a hard-to-treat spot.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You have a lung tumor that is very close to the windpipe, main airways, or esophagus (called 'ultra-central').
- Surgery is not an option for you, and your cancer team has approved this type of radiation.
- You can have an MRI (no severe claustrophobia or unsafe implants).
- You are not receiving chemotherapy or targeted therapy at the same time as radiation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a specialized radiation therapy that uses daily MRI scans to precisely target lung tumors located near the windpipe or esophagus. It aims to improve treatment accuracy while reducing side effects.
This trial tests a new type of radiotherapy that uses MRI scans to guide the radiation beam more precisely. It aims to treat tumors while reducing damage to healthy tissue.
This study tests a type of high-precision radiation guided by MRI pictures to treat certain cancers. It may help doctors deliver radiation more accurately while avoiding nearby healthy tissue, but you must be able to safely complete an MRI scan and meet tumor-size and health requirements.
This trial tests a newer way to plan and deliver radiation for prostate cancer using real-time MRI guidance. It may help by aiming high-dose treatment precisely while treating nearby disease and (in some cases) limited metastatic spots.
This Phase 2 study tests an MRI-guided radiation machine (an MR LINAC) to deliver very focused treatment to spine tumors. It may help by improving accuracy while treating up to a small number of spine levels affected by cancer.
This trial checks whether it’s practical and safe to deliver radiation treatment using real-time MRI guidance, with the process supported online. It may help patients whose doctors recommend radiation by testing a modern way to plan and deliver treatment more precisely.
Hear when a new Ultracentral Pulmonary Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.